Patent number four for endoxifen and 91 for Steven Quay. $ATOS #breastcancer
This fourth issued patent by the United States Patent and Trademark Office expands Atossa’s protection to include (Z)-endoxifen salt compositions and methods of using those. The broader protection provided by this new patent will create long-term stockholder value as it further validates and expands Atossa’s patent protection beyond our previously issued composition of matter patents, including U.S. Patent No. 11,572,334. #breastcancer $ATOS https://lnkd.in/gYUiE4Uq